Cvs Health (CVS) Annual Income Statement

Annual · GAAP · USD millions
Access CVS quarterly income statements →
The income statement data below highlights shifts in Cvs Health's operating performance over recent quarters.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
2025
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax249,908.00
Total Revenue402,067.00
Costs & Expenses
Cost of Goods and Services Sold221,167.00
Gross Profit55,362.00
Goodwill, Impairment Loss5,725.00
Other operatinig exp. /-income47,613.00
Total operating costs including COS397,407.00
Operating income / -loss4,660.00
Interest Expense0.00
Net Interest (-)Expense / Income0.00
Extinguishment of Debt0.00
Net Investment Income2,233.00
Other loss/ -income291.00
Total costs & expenses399,931.00
Income & Taxes
Income / -loss before income taxes2,136.00
Income taxes expenses / -benefit408.00
Income after income taxes1,728.00
Income / -loss from continuing operations1,728.00
Non-controlling interests40.00
Net income / -loss1,728.00
Income / -loss to shareholder1,768.00
EBIT2,136.00
EBITD6,742.00
EBITDA8,728.00
Earnings Per Share
Basic EPS (excl. extra items)1.40
Basic Net EPS1.40
Basic shares outstanding (Mill. of Units)1,267.00
Diluted Net EPS1.39
Diluted average shares (Mill. of Units)1,271.00
Dividend per share2.67
4 historic quarters locked

Sign in to unlock the full Cvs Health income statement history.

About Cvs Health Corp Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: February 10, 2026
  • Original filing: cvs-20251231.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.